Type 1 diabetic patients evolution to hypertension;Evolução para hipertensão arterial em pacientes com diabetes tipo 1

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 4, 2008, Pages 628-634

  Cobas, Roberta ^a,b   Santos, Bráulio ^a   Braga, Luiza ^a   Cunha, Edna Ferreira ^a   De Gomes, Marilia Brito ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UERJ ^*  (Brazil)

Author keywords

Hypertension; Prehypertension; Prevalence; Renal function; Type 1 diabetes

Indexed keywords

CREATININE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CHILD; CROSS-SECTIONAL STUDY; DIABETIC ANGIOPATHY; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LONGITUDINAL STUDY; MALE; PREVALENCE;

ADOLESCENT; ADULT; CHILD; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; PREVALENCE; YOUNG ADULT;

EID: 47249086117     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302008000400008     Document Type: Article

References (26)

1. The diabetes control and complications trial/epidemiology of diabetes interventions and complications research group. N Engl J Med. 2003;348:2294-303.
2. Nishimura R, LaPorte RE, Dorman JS, Tajma N, Becker D, Orchard TJ, et al. Mortality trends in type 1 diabetes. Diabetes Care. 2001;24(5):823-7.
3. Libby P, Nathan DM, Abraham K, Brunzell JD, Fradkin JE, Haffner SM, et al. National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation. 2005;111:3489-93.
4. Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR, et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia. 2003;46:760-5.
5. Laing SP, Swerdlow AJ, Carpenter LM, Slater SD, Burden AC, Botha JL, et al. Mortality from cerebrovascular disease in a cohort of 23000 patients with insulin-treated diabetes. Stroke. 2003;34:418-21.
6. Tuomilehto J, Borch-Johnsen K, Molarius A, Forsén T, Rastenyte D, Sarti C, Reunanen A. Incidence of cardiovascular disease in type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia. 1998;41:784-90.
7. Mathiesen ER, Ronn B, Storm B, Foght H, Deckert T. The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabetic Medicine. 1995;12:482-7.
8. Maahs DM, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson J, et al. Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care. 2005;28:301-6.
9. Norgaard K, Feldt-Rasmussen B, Borch-Johnsen K, Saelan H, Deckert T. Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1990;33(7):404-10.
10. Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY, Kinder LS, et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes. 10-year follow-up data from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2003;26:1374-9.
11. Orchard TJ, Forrest KY, Kuller LH, Becker DJ. Lipid and blood pressure treatment goals for type 1 diabetes. 10-year incidence data from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2001;24:1053-9.
12. JNC 7. The Seventh Report of the Joint National Comittee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. U.S. Department of Health and Human Services. National Institute of Health. National Heart, Lung and Blood Institute. NIH Publication No. 03-5233 December 2003.
13. Standards of Medical Care in Diabetes. Diabetes Care. 2005;28:S4-36.
14. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. Pediatrics. 2004;114:555-75.
15. Tratamento e acompanhamento do diabetes mellitus. Diretrizes da Sociedade Brasileira de Diabetes, 2006. Disponível em: www.diabetes.org.br/ ploticas/diretrizesonline.php. [Acessado em 14/jun/2007]
16. Delfino VDA, Mocelin AJ. Efeitos renais adversos dos anti- inflamatórios não hormonais. Uma abordagem pratica. J Bras Nefrol. 1995;17(4)199-205.
17. Walsh MG, Zgibor J, Borch-Jonnsen K, Orchard TJ. A multinational comparison of complications assessment in type 1 diabetes. The diamond substudy of complications (DiaComp) level 2. Diabetes Care. 2004;27:1610-7.
18. Soedamah-Muthu SS, Colhoun HM, Abrahamian H, Chan NN, Mangili R, Reboldi GP, et al. The EURODIAB prospective complications study group: trends in hypertension management in type 1 diabetes across Europe, 1989/1990-1997/1999. Diabetologia. 2002;45:1362-71.
19. The writing team of diabetes controls and complications trial/epidemiology of diabetes intervention and complications research group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy. The epidemiology of diabetes intervention and complications (EDIC) study. JAMA. 2003;290:2159-67.
20. Rönnback M, Fagerudd J, Forsblom C, Pettersson-Fernholm K, Reunanen A. Per-Henrik Groop and on behalf of the finnish diabetic nephropathy. Altered age-related blood pressure pattern in type 1 diabetes. Circulation. 2004;110;1076-82.
21. Giannattasio C, Failla M, Piperno A, Grappiolo A, Gamba P, Paleari F, et al. Early impairment of large artery structure and function in Type I diabetes mellitus. Diabetologia. 1999;42:987-94.
22. Piccini RX, Victora CG. Hipertensão arterial sistêmica em área urbana no sul do Brasil: prevalência e fatores de risco. Rev Saúde Pública. 1994;28(4):261-7.
23. Moura AA, Silva MAM, Ferraz MRT, Rivera IR. Prevalência de pressão arterial elevada em escolares e adolescentes de Maceió. J Pediatr (Rio J.). 2004;80:35-40.
24. Giunti S, Barit D, Cooper ME. Mechanisms of diabetic nephropathy: role of hypertension. Hypertension. 2006;48:519-26.
25. Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ. 2004;328:1105.
26. Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage. Implications for therapy. Hypertension. 2004;44:596-601.